Zhejiang Huunda Biotechnology Co., Ltd.
Zhejiang Biotechnology, established in 2020, develops pharmaceutical active substances via microbial fermentation, with a focus on anti-tumor drugs, anti-infections, mRNA intermediates, and health products.
Introduction
Zhejiang Zhejiang Biotechnology Co., Ltd., established in 2020, specializes in the research and development of pharmaceutical active substances (API), intermediates, and large health products derived from microbial fermentation or semi-synthetic fermentation. With a robust research and development capability, the company has fully established its development and production platform. Currently, its research and production pipeline focuses on antibody coupling toxins, anti-tumor, anti-infection, and anti-parasitic drugs, as well as mRNA intermediates, biological materials, and large health products.
More Websites
ICL Industrial Products, a subsidiary of ICL, produces and markets bromine and related chemicals.
GATHER Industrie GmbH, since 1976, manufactures high-quality magnetic-drive gear pumps and quick-disconnect couplings, attributing their success to qualified expertise.